Long-term therapeutic effects on parkinsonian rats of intrastriatal co-grafts with genetically engineered fibroblasts expressing tyrosine hydroxylase and glial cell line-derived neurotrophic factor

International Journal of Neuroscience

Volumn 115, Issue 6, 2005, Pages 769-779

  Zhang, Jingzhong ^a   Yang, Hui ^a   Duan, Deyi ^a   Duan, Chunli ^a   Zhao, Chunli ^a   Sun, Xiaohong ^a   Zhang, Jinlu ^a   Xu, Qunyuan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

GDNF; Gene therapy; Parkinson's disease; TH

Indexed keywords

APOMORPHINE; COMPLEMENTARY DNA; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NEOMYCIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MICRODIALYSIS; MOTOR ACTIVITY; NEUROLOGIC DISEASE; NONHUMAN; PARKINSONISM; PLASMID; RAT; ROTATION;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; FIBROBLASTS; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE GROWTH FACTORS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; TIME; TYROSINE 3-MONOOXYGENASE;

EID: 20044364602     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450590881542     Document Type: Article

References (18)

1. Bencsics, C., Wachtel, S. R., Milstien, S., Hatakeyama, K., Backer, J. B., & Rang, U. J. (1996). Double transduction with GTP Cyclohydrolase I and Tyrosine Hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts. Journal of Neuroscience, 16, 4449-4456.
2. Cunningham, L. A., & Su, C. (2002). Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Experimental Neurology, 174, 230-242.
3. Dai, X. L., Zhang, J. L., Xu, Q. Y., Zhao, C. L., Zhao, H. Y., Sun, X. H., & Zheng, S. P. (2000). An experimental study on gene therapy with intracerebral transplantation of microcapsulated human fibroblasts expressing TH gene in rat model of Parkinson's Disease. Acta AnatomicaSinica, 31, 317-321.
4. Duan, D. Y., Sun, C. S., Yang, Y. W., Yu, F. S., Zhang, J. L., & Xu, Q. Y. (2001). RT-PCR analysis of GDNF expression in glioma cell and cDNA cloning of precursor protein and mature peptide of GDNF. Journal of Neuroanatomy, 17, 6-10.
5. Haavik, J., & Toska, K. (1998). Tyrosine hydroxylase and Parkinson's disease. Molecular Neurobiology, 6, 285-309.
6. Hou, J. G., & Mytilineou, C. (1996). Secretion of GDNF by glial cells does not account for the neurotrophic effect of bFGF on dopamine neurons in vitro. Brain Research, 724, 145-148.
7. Ishida, A., & Yasuzumi, F. (2000). Approach to ex vivo gene therapy in the treatment of Parkinson's disease. Brain & Development, 22, 143-147.
8. Jiao, S., Cheng, L., Wloff, J. A., & Yang, N. S. (1993). Particle bombardment-mediated gene transfer and expression in rat brain tissue. Biotechnology, 11, 497-502.
9. Lotharius, J., & Brundin, P. (2002). Pathogenesis of Parkinson's disease: Dopamine, vesicles and α-synuclein. Nature Reviews Neuroscience, 3, 1-11.
10. Kafri, T. (2001). Lentivirus vectors: Difficulties and hopes before clinical trials. Current Opinion in Molecular Therapeutics, 3, 316-326.
11. Lapchak, P. A., Miller, P. J., Collins, F., & Jiao, S. (1997). Glial cell line-derived neurotrophic factor attenuates behavioral deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: Comparison of intraventricular and intranigral delivery. Neuroscience, 78, 61-72.
12. Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S., & Collins, F. (1993). GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260, 1130-1132.
13. MacGregor, G. R., & Caskey, C. T. (1989). Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Research, 17, 2365.
14. Palfi, S., Leventhal, L., Chu, Y., Ma, S. Y., Emborg, M., Bakay, R., Deglon, N., Hantraye, R., Aebischer, P., & Kordower, J. H. (2002). Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. Journal of Neuroscience, 22, 4942-4954.
15. Rosenblad, C., Kirik, D., Devaux, B., Moffat, B., Phillips, H. S., & Bjorklund, A. (1999). Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. The European Journal of Neuroscience, 11, 1554-1566.
16. Xiao, H., Hirata, Y., Isobe, K., & Kiuchi, K. (2002). Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines. Journal of Neurochemistry, 82, 801-808.
17. Xu, Q., Tian, J., Zhang, J., Yang, H., Zheng, S., & Liu, Y (1998). An experimental study on rat model of parkinsonizm by gene therapy. Chinese Medical Journal, 111, 154-159.
18. Zhou, J., Zhang, J. L., Xu, Q. Y., Zhao, C. L., Cai, Q., & Sun, X. H. (2001). An experimental study on gene therapy of Parkinsonism by transplantation of microcapsulated TH-expressing muscles cells. Journal of Neuroanatomy, 17, 29-34.